BOR15001L7

DRUG2 trials

Sponsors

Laboratoire Boreaderme Inc.

Conditions

Herpes LabialisRecurrent Herpes Labialis

Phase 2

An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis

Laboratoire Boreaderme Inc.Recurrent Herpes Labialis

Start: 2020-09-30End: 2022-07-31Target: 164Updated: 2020-09-07

Unknown Phase

Study of a New Topical Natural Health Product for the Treatment of Herpes Labialis

Laboratoire Boreaderme Inc.Herpes Labialis

Start: 2016-01-31End: 2017-09-30Target: 40Updated: 2017-03-09